Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial

ConclusionsThe results of the current study suggest that although knowledge concerning the probability of having aBRCA1 and/orBRCA2 pathogenic variant remains low in this patient population, the interactive decision tool improved rates compared with a static Web site. As interest in genetic testing continues to rise, so will the need to integrate tools into the treatment decision process to improve informed decision making.

Source: Cancer - November 13, 2018 Category: Cancer & Oncology Authors: Michele C. Gornick, Allison W. Kurian, Lawrence C. An, Angela Fagerlin, Reshma Jagsi, Steven J. Katz, Sarah T. Hawley Tags: Original Article Source Type: research